Valuation for Cosmo Pharmaceuticals N.V. (id:13088 COPN)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 14.78 |
|
|
| Forward P/E | 10.76 |
|
|
| Price to sales | 5.17 |
|
|
| Price to book | 1.92 |
|
|
| Enterprise to revenue | 4.44 |
|
|
| Enterprise to ebitda | 8.24 |
|
|